Thymidine Phosphorylase in Breast Cancer
Author Information
Author(s): SB Fox, M Westwood, A Moghaddam, M Comley, H Turley, RM Whitehouse, R Bicknell, KC Gatter, AL Harris
Primary Institution: University of Oxford, John Radcliffe Hospital
Hypothesis
The expression of thymidine phosphorylase (TP) in breast carcinomas and its correlation with tumor variables and prognosis.
Conclusion
Thymidine phosphorylase is up-regulated in breast cancer and may serve as a predictive marker for chemotherapy response.
Supporting Evidence
- TP expression was observed in 53% of tumors.
- Immunoreactivity was present in 61% of tumors at the tumor periphery.
- TP expression was significantly inversely correlated with tumor grade and size.
- Node-positive patients with elevated TP had higher relapse-free survival.
Takeaway
This study looked at a protein called thymidine phosphorylase in breast cancer and found that it might help doctors predict how well patients will respond to treatment.
Methodology
Ribonuclease protection assays and immunohistochemistry were used to examine TP expression in breast carcinomas.
Limitations
The study did not satisfactorily quantify the stromal and inflammatory cell elements, which may affect the results.
Participant Demographics
{"age":{"median":57,"range":"28-82"},"surgical_treatment":{"lumpectomy":176,"simple_mastectomy":64},"adjuvant_treatment":{"chemotherapy":56,"tamoxifen":135},"lymph_nodes":{"negative":140,"positive":100},"tumor_size":{"median":2.2,"range":"0.8-8"},"histology":{"ductal":188,"lobular":25,"others":27},"grade":{"I":24,"II":85,"III":79}}
Statistical Information
P-Value
{"tumor_grade":0.05,"tumor_size":0.003,"relapse_free_survival":0.05}
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website